PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application
Go back to PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application| (NASDAQ: PYPD) | Delayed: 4.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.76 | 52 Week High | $ | |||
| Open | $4.76 | 52 Week Low | $ | |||
| Day High | $4.76 | P/E | N/A | |||
| Day Low | $4.76 | EPS | $ | |||
| Volume | 65 | |||||
